Skip to main content
OpenTrials
Completed

NCT Number: NCT04071808

Painless Myocardial Ischemia in Diabetic Patients.

This study aims to investigate the relationship between the concentrations of blood orphanin, norepinephrine and the morbidity of painless myocardial ischemia in patients with diabetes mellitus. Hopefully, the biomarker(s) in the blood of diabetic patients can be found for screening high risk patients in the diabetes sufferers to prevent the painless myocardial ischemia.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Painless Myocardial Ischemia

Age range

18 year–75 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Second of Shanxi Medical University

Taiyuan, Shanxi, 030001, China

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Subject has diabetes

Exclusion criteria

  • History of myocardial ischemia
  • Symptoms of myocardial ischemia（ECG changes except）

Treatment and study plan

ELISA test

Diagnostic Test

The levels of orphanin and norepinephrine in blood of diabetic patients with painless myocardial ischemia requiring interventional therapy and diabetic patients without interventional therapy were measured.

Primary outcomes

  1. Blood orphanin content

    Time frame: 24 hours

    Blood orphanin levels in painless diabetic patients with myocardial ischemia requiring interventional therapy and diabetic patients without interventional therapy.

  2. Blood norepinephrine content

    Time frame: 24 hours

    Blood norepinephrine levels in diabetic patients with painless myocardial ischemia requiring interventional therapy and diabetic patients without interventional therapy

Sponsors and collaborators

Lead sponsor

Second Hospital of Shanxi Medical University

Other

Registry information

Official study title

Changes of Plasma Orphanin and Norepinephrine Levels in Patients With Painless Myocardial Ischemia and Diabetes Mellitus.

Important dates

Study start
2019
Primary completion
2019
Study completion
2020
First posted
Aug 28, 2019
Registry last updated
Apr 20, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.